Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juho Alaviuhkola

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Protein Engineering, Design & Selection : PEDS|September 21, 2022
Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximityAlbert Galera-Prat, Juho Alaviuhkola, Heli I Alanen, et al.
ACS Chemical Biology|June 13, 2025
Discovery of Inhibitors for Bacterial Arr Enzymes ADP-Ribosylating and Inactivating Rifamycin AntibioticsJuho Alaviuhkola, Sondos Abdulmajeed, Sven T Sowa, et al.
Journal of Medicinal Chemistry|December 27, 2025
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP InhibitionKonstantinos A Ouzounthanasis, Chiara Bosetti, Juho Alaviuhkola, et al.
European Journal of Medicinal Chemistry|February 21, 2025
Substitutions at the C-8 position of quinazolin-4-ones improve the potency of nicotinamide site binding tankyrase inhibitorsChiara Bosetti, Dionysis Kampasis, Shoshy A Brinch, et al.
European Journal of Medicinal Chemistry|September 6, 2025
Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10Juho Alaviuhkola, Maria Giulia Nizi, Chiara Vagaggini, et al.
European Journal of Medicinal Chemistry|May 2, 2022
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15Maria Giulia Nizi, Mirko M Maksimainen, Sudarshan Murthy, et al.
Journal of Medicinal Chemistry|January 4, 2023
[1,2,4]Triazolo[3,4-<i>b</i>]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP EnzymesSudarshan Murthy, Maria Giulia Nizi, Mirko M Maksimainen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|September 21, 2022
Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximityAlbert Galera-Prat, Juho Alaviuhkola, Heli I Alanen, et al.
ACS Chemical Biology|June 13, 2025
Discovery of Inhibitors for Bacterial Arr Enzymes ADP-Ribosylating and Inactivating Rifamycin AntibioticsJuho Alaviuhkola, Sondos Abdulmajeed, Sven T Sowa, et al.
Journal of Medicinal Chemistry|December 27, 2025
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP InhibitionKonstantinos A Ouzounthanasis, Chiara Bosetti, Juho Alaviuhkola, et al.
European Journal of Medicinal Chemistry|February 21, 2025
Substitutions at the C-8 position of quinazolin-4-ones improve the potency of nicotinamide site binding tankyrase inhibitorsChiara Bosetti, Dionysis Kampasis, Shoshy A Brinch, et al.
European Journal of Medicinal Chemistry|September 6, 2025
Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10Juho Alaviuhkola, Maria Giulia Nizi, Chiara Vagaggini, et al.
European Journal of Medicinal Chemistry|May 2, 2022
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15Maria Giulia Nizi, Mirko M Maksimainen, Sudarshan Murthy, et al.
Journal of Medicinal Chemistry|January 4, 2023
[1,2,4]Triazolo[3,4-<i>b</i>]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP EnzymesSudarshan Murthy, Maria Giulia Nizi, Mirko M Maksimainen, et al.
Pageof 1